William J Bosche

6PUBLICATIONS
47CO-AUTHORS
Medical virologyMedical infection agents (incl. prions)Gene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 17, 2022
Myeloid cell tropism enables MHC-E-restricted CD8+ T cell priming and vaccine efficacy by the RhCMV/SIV vaccine.

Scott G Hansen, Meaghan H Hancock, Daniel Malouli

|Jul 06, 2021
Interleukin-15 response signature predicts RhCMV/SIV vaccine efficacy.

Fredrik Barrenäs, Scott G Hansen, Lynn Law

|Mar 26, 2021
Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy.

Marieke C Verweij, Scott G Hansen, Ravi Iyer

|Mar 26, 2021
Cytomegaloviral determinants of CD8+ T cell programming and RhCMV/SIV vaccine efficacy.

Daniel Malouli, Scott G Hansen, Meaghan H Hancock

|Jul 19, 2019
A live-attenuated RhCMV/SIV vaccine shows long-term efficacy against heterologous SIV challenge.

Scott G Hansen, Emily E Marshall, Daniel Malouli

|Feb 22, 2018
Liver macrophage-associated inflammation correlates with SIV burden and is substantially reduced following cART.

Bridget S Fisher, Richard R Green, Rachel R Brown

Pageof 1